Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Return on Invested Capital (2023 - 2024)

Mereo BioPharma (MREO) has disclosed Return on Invested Capital for 2 consecutive years, with 12.98% as the latest value for Q3 2024.

  • Quarterly Return on Invested Capital changed N/A to 12.98% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 12.98% through Sep 2024, changed N/A year-over-year, with the annual reading at 1.24% for FY2021, N/A changed from the prior year.
  • Return on Invested Capital for Q3 2024 was 12.98% at Mereo BioPharma, down from 0.65% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.55% in Q4 2023, with the low at 12.98% in Q3 2024.